Future studies with this model could analyze (a) hepcidin increase as a defensin in patients with CKD that exacerbates anemia [86] or (b) the effect of increased levels of inflammatory load of cytokines in patients with CKD anemia that causes the RBC lifespan to decrease [73, 86, 87]. This evidence concerns the gene HAMP and chronic kidney disease.